Summary: At Sleep 2024, Avadel will present new data on Lumryz, the initially extended-launch, when-nightly formulation of sodium oxybate for narcolepsy. Findings highlighted client preference for Lumryz around twice-nightly oxybate, with 94% preferring when-nightly dosing and … [Read more...]
Avadel Reports Uptick in Lumryz Therapy Adoption for Narcolepsy
Summary: Avadel Prescription drugs reported a considerable improve in Lumryz use for narcolepsy, with around 1,700 individuals initiating therapy—a 70% rise considering the fact that December. The enterprise is searching to expand Lumryz’s indications into pediatric treatment … [Read more...]